Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Stage II Prostate Adenocarcinoma × BAY 86-7548 × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 6 Neoplasms 2 Breast Neoplasms 2 Urogenital Neoplasms 1 Stage II Prostate Adenocarcinoma 1 Prostate Adenocarcinoma 1 Neoplasms by Site 1 Genital Neoplasms, Male 1 Genital Diseases, Male 1

Interventions

Magnetic Resonance Spectroscopy 2 prednylidene 1 gallium 68 PSMA-11 1 deltacortene 1 apalutamide 1 Prednisone 1 Gonadotropin-Releasing Hormone 1 BAY 86-7548 1 Abiraterone Acetate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03113617 2023-12-12

68Ga-RM2 PET/CT in Detecting Regional Nodal and Distant Metastases in Patients With Intermediate or High-Risk Prostate Cancer

Stanford University

Phase 2 Completed

44 enrolled 8 charts

Stage II Prostate Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡